Skip to main content

. 1946 Jul;25(4):497–527. doi: 10.1172/JCI101733

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VI. THE TREATMENT OF COMPLICATIONS OF ARSENO-THERAPY WITH BAL (BRITISH ANTI-LEWISITE) ^¹

A B Carleton ^1,^2,^3,^4,⁵, R A Peters ^1,^2,^3,^4,⁵, L A Stocken ^1,^2,^3,^4,⁵, R H S Thompson ^1,^2,^3,^4,⁵, D I Williams ^1,^2,^3,^4,⁵, I D E Storey ^1,^2,^3,^4,⁵, G A Levvy ^1,^2,^3,^4,⁵, A C Chance ^1,^2,^3,^4,⁵

PMCID: PMC435589 PMID: 21001625

497

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Levvy G. A. The iodometric micro-determination of arsenic in biological material. Biochem J. 1943;37(5):598–601. doi: 10.1042/bj0370598. [DOI] [PMC free article] [PubMed] [Google Scholar]
Longcope W. T., Luetscher J. A., Wintrobe M. M., Jäger V. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL. J Clin Invest. 1946 Jul;25(4):528–533. doi: 10.1172/JCI101734. [DOI] [PMC free article] [PubMed] [Google Scholar]
Sulzberger M. B., Baer R. L., Kanof A. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). V. SKIN SENSITIZATION TO BAL. J Clin Invest. 1946 Jul;25(4):488–496. doi: 10.1172/JCI101732. [DOI] [PMC free article] [PubMed] [Google Scholar]
Wexler J., Eagle H., Tatum H. J., Magnuson H. J., Watson E. B. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). II. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN NORMAL SUBJECTS AND AFTER MINIMAL EXPOSURE TO ARSENICAL SMOKE. J Clin Invest. 1946 Jul;25(4):467–473. doi: 10.1172/JCI101729. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES